Portfolio Company · Operating Co.

Kriya Therapeutics

Not on record

backed byPatient Square Capital

Current

Kriya Therapeutics

a portfolio company of

Patient Square Capital

Status on record: Current

PE Firm Index

Who owns Kriya Therapeutics?

Kriya Therapeutics is listed as a current portfolio company of Patient Square Capital on Patient Square Capital's own portfolio page.

Company Snapshot

Kriya Therapeutics' owner on record, Patient Square Capital, is a firm. Patient Square Capital lists 18 companies in the index.

SectorNot on record

Parent PE firmPatient Square Capital

Ownership statusCurrent

WebsiteNot on record

About the owner

Patient Square Capital

Companies in the index: 18

Health-care dedicated investment firm.

Read the Patient Square Capital profile

Questions about Kriya Therapeutics

Who owns Kriya Therapeutics?

Kriya Therapeutics is listed as a current portfolio company of Patient Square Capital on Patient Square Capital's own portfolio page.

Sources

Patient Square Capital's page on Kriya Therapeutics
Patient Square Capital
https://patientsquarecapital.com/portfolio

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Kriya Therapeutics and does not provide investment advice.

Other portfolio companies of Patient Square Capital

6 of 17 shown

Elevage Medical Technologies

Enavate Sciences

See the full Patient Square Capital portfolio.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Parent PE firm

Patient Square Capital

Status: Current

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.